CLC Number:
- R473.74
| [1] Benjamin EJ, Blaha MJ, Chiuve SE, et al.Heart Disease and Stroke Statistics-2017 Update:A Report from the American Heart Association[J].Circulation,2017, 135(10):e146-e603. DOI:10.1161/CIR.0000000000000485. [2] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志, 2018,51(9):666-682. DOI:10.3760/cma.j.issn.1006-7876.2018.09.004. [3] Wardlaw JM, Murray V, Berge E, et al.Recombinant Tissue Plasminogen Activator for Acute Ischaemic Stroke:An Updated Systematic Review and Meta-analysis[J].Lancet,2012,379(9834):2364-2372. DOI:10.1016/S0140-6736(12)60738-7. [4] Chen YW, Sung SF,Chen CH, et al.Intravenous Thrombolysis Administration 3-4.5h after Acute Ischemic Stroke: A Retrospective, Multicenter Study[J].Front Neurol,2019,10:1038. DOI:10.3389/fneur.2019.01038. [5] Powers WJ, Rabinstein AA, Ackerson T, et al.Guidelines forthe Early Management of Patients with Acute Ischemic Stroke:2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke:A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association[J].Stroke, 2019,50(12):e344-e418. DOI:10.1161/STR.0000000000000211. [6] Romano JG,Smith EE,Liang L,et al.Outcomes in Mild Acute Ischemic Stroke Treated with Intravenous Thrombolysis:A Retrospective Analysis of the Get with the Guidelines-stroke Registry[J].JAMA Neurol, 2015, 72(4):423-431. DOI:10.1001/jamaneurol.2014.4354. [7] Saposnik G, Kapral MK, Liu Y, et al.iScore:A Risk Score to Predict Death Early after Hospitalization for an Acute Ischemic Stroke[J].Circulation, 2011, 123(7):739-749. DOI: 10.1161/CIRCULATIONAHA.110.983353. [8] Saposnik G, Raptis S, Kapral MK, et al.The iScore Predicts Poor Functional Outcomes Early after Hospitalization for an Acute Ischemic Stroke[J].Stroke, 2011, 42(12):3421-3428. DOI:10.1161/STROKEAHA.111.623116. [9] Saposnik G, Demchuk A, Tu JV,et al.The iScore Predicts Efficacy and Risk of Bleeding in the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Stroke Trial[J].J Stroke Cerebrovasc Dis,2013,22(6):876-882. DOI:10.1016/j.jstrokecerebrovasdis.2012.09.001. [10] Park TH, Park SS,Ko Y,et al.The iScore Predicts Clinical Response to Tissue Plasminogen Activator in Korean Stroke Patients[J].J Stroke Cerebrovasc Dis, 2014,23(2):367-373. DOI:10.1016/j.jstrokecerebrovasdis.2013.05.025. [11] Strbian D,Engelter S,Michel P,et al.Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis: The SEDAN Score[J].Ann Neurol, 2012,71(5):634-641. DOI:10.1002/ana.23546. [12] Al-Khaled M, Langner B, Brüning T.Predicting Risk of Symptomatic Intracerebral Hemorrhage and Mortality after Treatment with Recombinant Tissue-plasminogen Activator Using SEDAN Score[J].Acta Neurol Scand, 2016,133(4):239-244. DOI:10.1111/ane.12447. [13] Flint AC, Cullen SP, Faigeles BS, et al.Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks in Vascular Events Score[J].Am J Neuroradiol,2010,31(7):1192-1196. DOI:10.3174/ajnr.A2050.[14] Flint AC, Kamel H, Rao VA, et al.Validation of the Totaled Health Risks in Vascular Events (THRIVE) Score for Outcome Prediction in Endovascular Stroke Treatment[J].Int J Stroke,2014, 9(1):32-39. DOI10.1111/j.1747-4949.2012.00872.x. [15] Flint AC, Faigeles BS, Cullen SP,et al.THRIVE Score Predicts Ischemic Stroke Outcomes and Thrombolytic Hemorrhage Risk in VISTA[J].Stroke,2013,44(12):3365-3369. DOI:10.1161/STROKEAHA.113.002794. [16] Flint AC, Gupta R, Smith WS, et al.The THRIVE Score Predicts Symptomatic Intracerebral Hemorrhage after Intravenous tPA Administration in SITS-MOST[J].Int J Stroke,2014,9(6):705-710. DOI:10.1111/ijs.12335. [17] Mazya M, Egido JA, Ford GA, et al.Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated with Intravenous Alteplase: Safe Implementation of Treatments in Stroke(SITS) Symptomatic Intracerebral Hemorrhage Risk Score[J].Stroke,2012,43(6):1524-1531. DOI: 10.1161/STROKEAHA.111.644815. [18] Nisar T, Hanumanthu R, Khandelwal P.Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models[J].J Stroke Cerebrovasc Dis,2019,28(11):104360. DOI:10.1016/j.jstrokecerebrovasdis.2019.104360. [19] Cappellari M,Turcato G, Forlivesi S,et al.STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke[J].Stroke,2018,49(2):397-404. DOI:10.1161/STROKEAHA.117.018427. [20] Diedler J, Ahmed N, Sykora M, et al.Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset[J].Stroke,2010,41(2):288-294. DOI:10.1161/STROKEAHA.109.559724. [21] Cucchiara B, Kasner SE, Tanne D, et al.Factors Associated with Intracerebral Hemorrhage after Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials[J].Stroke, 2009,40(9):3067-3072. DOI:10.1161/STROKEAHA.109.554386. [22] Ruecker M, Matosevic B, Willeit P, et al.Subtherapeutic Warfarin Therapy Entails an Increased Bleeding Risk after Stroke Thrombolysis[J].Neurology,2012,79(1):31-38. DOI: 10.1212/WNL.0b013e31825dcdf0. [23] Miedema I, Luijckx GJ, De Keyser J, et al.Thrombolytic Therapy for Ischaemic Stroke in Patients Using Warfarin: A Systematic Review and Meta-analysis[J].J Neurol Neurosurg Psychiatry,2012, 83(5):537-540. DOI:10.1136/jnnp-2011-301794. [24] Xian Y, Liang L, Smith EE, et al.Risks of Intracranial Hemorrhage among Patients with Acute Ischemic Stroke Receiving Warfarin and Treated with IntravenousTissue Plasminogen Activator[J].JAMA,2012,307(24):2600-2608. DOI:10.1001/jama.2012.6756. [25] Lokeskrawee T, Muengtaweepongsa S, Patumanond J, et al.Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score[J].J Stroke Cerebrovasc Dis,2017, 26(11):2622-2629. DOI:10.1016/j.jstrokecerebrovasdis.2017.06.030. [26] Pan Y, Peng Y, Chen W,et al.THRIVE-c Score Predicts Clinical Outcomes in Chinese Patients after Thrombolysis[J].Brain Behav,2018,8(2):e00927. DOI:10.1002/brb3.927. [27] Xu X, Li C, Wan T, et al.Risk Factors for Hemorrhagic Transformation Following Intravenous Thrombolysis in Acute Cerebral Infarction:A Retrospective Single Center Study[J].World Neurosurgery, 2017,101:155-160. DOI:10.1016/j.wneu.2017.01.091. [28] 常红,赵洁,王晓娟,等.急性缺血性脑卒中患者静脉溶栓后出血预警模型的构建[J].中华护理杂志, 2019, 54(11):1648-1652. DOI:10.3761/j.issn.0254-1769.2019.11.010. [29] Wang R, Zeng J, Wang F,et al.Risk Factors of Hemorrhagic Transformation after Intravenous Thrombolysis with rt-PA in Acute Cerebral Infarction[J].QJM, 2019,112(5):323-326. DOI:10.1093/qjmed/hcy292. |
| [1] | . [J]. Journal of Nursing, 2021, 28(12): 71-74. |
| [2] | . [J]. Journal of Nursing, 2021, 28(12): 75-78. |
| [3] | WANG Run, ZHOU Chun-lan, YU Mei, ZHOU Jun-gui, LIU Yu, YANG Li-xiao, YE Xiao-ling. Evidence Summary of Speech and Language Rehabilitation Management in Patients with Post-stroke Aphasia [J]. Journal of Nursing, 2021, 28(11): 16-20. |
| [4] | CHENG Shuang, XIONG Zhen-fang, CAI Yi, CHEN Han-bin, HUI Jing-rui. Qualitative Studies on Parents’ Experiences of Diagnostic Process for Children with Autism Spectrum Disorder: A Systematic Review [J]. Journal of Nursing, 2021, 28(9): 35-42. |
| [5] | ZHU Wei-wei, XU Yang-zi, HUO Wan-jun, CHEN Ci-yu, LI Yuan-tian, LING Dong-lan. Best Evidence Summary for Assessment and Management of Pain in Elderly Patients with Dementia [J]. Journal of Nursing, 2021, 28(5): 32-37. |
| [6] | . [J]. Journal of Nursing, 2021, 28(5): 55-58. |
| [7] | CHEN Jun-shan, FAN Jie-mei, YU Jin-tian, ZHANG Ai-qin. Development and Validation of Delirium Prediction Model for Neurosurgical ICU Patients [J]. Journal of Nursing, 2021, 28(4): 1-8. |
| [8] | . [J]. Journal of Nursing, 2021, 28(2): 42-46. |
| [9] | . [J]. Journal of Nursing, 2020, 27(23): 64-67. |
| [10] | . [J]. Journal of Nursing, 2020, 27(23): 32-36. |
| [11] | HUANG Hou-qiang, GUO Sheng-min, YE Li, ZHENG Si-lin. Best Evidence Summary of Prevention and Management of Hemiplegic Shoulder Pain in Stroke Patients [J]. Journal of Nursing, 2020, 27(23): 37-41. |
| [12] | . [J]. Journal of Nursing, 2020, 27(18): 50-54. |
| [13] | . [J]. Journal of Nursing, 2020, 27(15): 29-32. |
| [14] | LV Pan-pan, WANG Qian-bei, LI Chao-yue, ZHANG Ning. Clinical Characteristic and Nursing of Patients with Morvan's Syndrome: A 6-case Study [J]. Journal of Nursing, 2020, 27(15): 60-62. |
| [15] | . [J]. Journal of Nursing, 2020, 27(10): 32-35. |
|